Search
for

    Sort by

    Research 511–540 of 1000+

    1. Evaluating Carthamus Oxyacantha For 5α-Reductase Inhibition: Therapeutic Perspectives In BPH Journal for ReAttach Therapy and Developmental Diversities · 2023
    2. Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing System Dynamics Review · 2020
    3. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    4. A Case of Gynecomastia Induced by Use of Doxazosin Korean Journal of Medicine · 2016
    5. Metastatic Melanoma of the Tongue: A Rare Case Actas Dermo-Sifiliográficas · 2012
    6. Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · 2007
    7. Minoxidil Reactions (Auckland) · 1987
    8. Diazepam-Induced Amnesia for Cardioversion JAMA · 1967
    9. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations
    10. Telocytes in human skin – are they involved in skin regeneration? Journal of Cellular and Molecular Medicine · 2012 · 160 citations
    11. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia Translational Andrology and Urology · 2019 · 110 citations
    12. Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies Food & Function · 2016 · 104 citations
    13. Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy Archives of Dermatology · 1963 · 74 citations
    14. Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers European Urology · 1994 · 73 citations
    15. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation Expert Opinion on Drug Safety · 2012 · 71 citations
    16. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas British Journal of Dermatology · 2003 · 68 citations
    17. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sciences · 2015 · 67 citations
    18. HRT for women with premature ovarian insufficiency: a comprehensive review Human Reproduction Open · 2017 · 61 citations
    19. JAK inhibitors and alopecia areata Lancet · 2019 · 56 citations
    20. Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering Journal of Cosmetic Dermatology · 2017 · 55 citations
    21. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    22. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase Scientific Reports · 2016 · 43 citations
    23. Toward a Diagnostic Score in Cushing's Syndrome Frontiers in Endocrinology · 2019 · 42 citations
    24. Subacute cutaneous lupus erythematosus presenting as erythroderma Journal of The American Academy of Dermatology · 1988 · 41 citations
    25. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects Case Reports · 2015 · 39 citations
    26. Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase. Biological & Pharmaceutical Bulletin · 2002 · 38 citations
    27. Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization Bioorganic & Medicinal Chemistry · 2009 · 37 citations
    28. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    29. Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome Experimental and Clinical Endocrinology & Diabetes · 2012 · 35 citations
    30. FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches Journal of clinical immunology · 2017 · 33 citations